Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...
The three largest pharmacy benefit managers are looking to take their legal back-and-forth with the Federal Trade Commission ...
The “Big Three” PBMs are kicking their suit up to the 8th Circuit and, in the meantime, are once again asking a Missouri ...
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...
CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...
MarketWatch on MSN10d
CVS’s stock is having its best day since 1999, after more than just earningsCVS is a PBM through its CVS Caremark business. Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results